Altimmune's average Accounts Receivable for the
three
months ended in Dec. 2023 was $0.99 Mil. Altimmune's Revenue for the
three
months ended in Dec. 2023 was $0.04 Mil.
Hence, Altimmune's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 2,450.19.
The historical rank and industry rank for Altimmune's Days Sales Outstanding or its related term are showing as below:
ALT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.68 Med: 128.39 Max: 550.07
Current: 436.63
During the past 13 years, Altimmune's highest Days Sales Outstanding was 550.07. The lowest was 10.68. And the median was 128.39.
ALT's Days Sales Outstanding is ranked worse than 92.58% of 889
companies
in the Biotechnology industry
Industry Median: 71.97
vs ALT: 436.63
Altimmune's Days Sales Outstanding
increased
from Dec. 2022 (0.00) to Dec. 2023 (2,450.19).
Altimmune Days Sales Outstanding Historical Data
The historical data trend for Altimmune's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Altimmune's Days Sales Outstanding
For the Biotechnology subindustry, Altimmune's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Altimmune's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Altimmune's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Altimmune's Days Sales Outstanding falls into.
Altimmune Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Altimmune (NAS:ALT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Altimmune Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Altimmune's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALT has been successfully added to your 